Search research articles
Contact Us
Filters
Showing results (211-220 of 440) with videos related to
Page
of 44
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2020
Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma
Nisha S Joseph, Jonathan L Kaufman, Madhav V Dhodapkar, et al.
Blood Cancer Journal
|
December 19, 2023
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience
Sara A Scott, Ellen M Marin, Kathryn T Maples, et al.
Frontiers in Immunology
|
September 18, 2025
Maturation of human early-minted blood antibody-secreting cells is coupled with increased IgG secretion rates
Doan C Nguyen, Ian T Hentenaar, Monica Cabrera-Mora, et al.
American Journal of Hematology
|
December 4, 2020
Natural history of multiple myeloma patients refractory to venetoclax: A single center experience
Kathryn T Maples, Ajay K Nooka, Vikas Gupta, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 27, 2019
Immunotherapy in Multiple Myeloma: Accelerating on the Path to the Patient
Irene Ghobrial, Calixto Hernández Cruz, Alfred Garfall, et al.
Blood Cancer Journal
|
December 5, 2024
Real-world characteristics and outcomes of patients with high-risk and non-high-risk smoldering multiple myeloma using the Flatiron Health database
S Vincent Rajkumar, María-Victoria Mateos, Marcy Schaeffer, et al.
Research Square
|
July 18, 2025
Mature Human Bone Marrow Plasma Cells Secrete More IgG than Early-Minted Blood Antibody-Secreting Cells
Doan C Nguyen, Ian T Hentenaar, Monica Cabrera-Mora, et al.
Transplantation and Cellular Therapy
|
October 9, 2021
Benefits of Autologous Stem Cell Transplantation for Elderly Myeloma Patients in the Last Quarter of Life
Nisha S Joseph, Vikas A Gupta, Sarah Wyman, et al.
Cancer
|
April 6, 2019
Daratumumab in multiple myeloma
Ajay K Nooka, Jonathan L Kaufman, Craig C Hofmeister, et al.
Blood Cancer Journal
|
August 1, 2023
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel
Noopur Raje, Kenneth Anderson, Hermann Einsele, et al.
Page
of 44
Search research articles
Search
Showing results (211-220 of 440) with videos related to
Sort By:
Page
of 44
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2020
Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma
Nisha S Joseph, Jonathan L Kaufman, Madhav V Dhodapkar, et al.
Blood Cancer Journal
|
December 19, 2023
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience
Sara A Scott, Ellen M Marin, Kathryn T Maples, et al.
Frontiers in Immunology
|
September 18, 2025
Maturation of human early-minted blood antibody-secreting cells is coupled with increased IgG secretion rates
Doan C Nguyen, Ian T Hentenaar, Monica Cabrera-Mora, et al.
American Journal of Hematology
|
December 4, 2020
Natural history of multiple myeloma patients refractory to venetoclax: A single center experience
Kathryn T Maples, Ajay K Nooka, Vikas Gupta, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 27, 2019
Immunotherapy in Multiple Myeloma: Accelerating on the Path to the Patient
Irene Ghobrial, Calixto Hernández Cruz, Alfred Garfall, et al.
Blood Cancer Journal
|
December 5, 2024
Real-world characteristics and outcomes of patients with high-risk and non-high-risk smoldering multiple myeloma using the Flatiron Health database
S Vincent Rajkumar, María-Victoria Mateos, Marcy Schaeffer, et al.
Research Square
|
July 18, 2025
Mature Human Bone Marrow Plasma Cells Secrete More IgG than Early-Minted Blood Antibody-Secreting Cells
Doan C Nguyen, Ian T Hentenaar, Monica Cabrera-Mora, et al.
Transplantation and Cellular Therapy
|
October 9, 2021
Benefits of Autologous Stem Cell Transplantation for Elderly Myeloma Patients in the Last Quarter of Life
Nisha S Joseph, Vikas A Gupta, Sarah Wyman, et al.
Cancer
|
April 6, 2019
Daratumumab in multiple myeloma
Ajay K Nooka, Jonathan L Kaufman, Craig C Hofmeister, et al.
Blood Cancer Journal
|
August 1, 2023
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel
Noopur Raje, Kenneth Anderson, Hermann Einsele, et al.
Page
of 44